NYSE:KVUE Kenvue (KVUE) Stock Forecast, Price & News $23.72 +0.35 (+1.50%) (As of 08/11/2023 08:48 PM ET) Add Compare Share Share Today's Range$23.25▼$23.8050-Day Range$23.35▼$26.5552-Week Range$22.49▼$27.80Volume46.06 million shsAverage Volume8.21 million shsMarket Capitalization$45.42 billionP/E RatioN/ADividend YieldN/APrice Target$28.11 ProfileProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial MediaProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media About Kenvue (NYSE:KVUE) StockKenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.Read More KVUE Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart KVUE Stock News HeadlinesAugust 13, 2023 | americanbankingnews.comKenvue Inc. (NYSE:KVUE) Given Average Rating of "Hold" by BrokeragesAugust 13, 2023 | americanbankingnews.comComparing Kenvue (NYSE:KVUE) and Nanophase Technologies (OTCMKTS:NANX)August 14, 2023 | Chaikin Analytics (Ad)His system isolated NVIDIA - Here's His Next Buy.Most investors don't know the truth about A.I. 50-year Wall Street Insider Marc Chaikin reveals what you should be doing to profit. Learn more here.August 11, 2023 | finance.yahoo.comKVUE Aug 2023 23.500 callAugust 11, 2023 | msn.comIs Kenvue Stock a Buy After Earnings?August 10, 2023 | nasdaq.comKenvue To Join S&P 500August 10, 2023 | nasdaq.comDown -7.52% in 4 Weeks, Here's Why You Should You Buy the Dip in Kenvue (KVUE)August 9, 2023 | msn.comKenvue Will be Added to S&P 500 After J&J Exchange OfferAugust 14, 2023 | Altimetry (Ad)Seven millionaires secretly enable market shock?A fraud expert to the FBI just shared a surprising new prediction. Own stocks? Watch it now.August 8, 2023 | benzinga.comKenvue Unusual Options ActivityAugust 5, 2023 | americanbankingnews.comInvestors Buy High Volume of Kenvue Call Options (NYSE:KVUE)August 4, 2023 | reuters.comKenvue can't ask appeals court to toss Tylenol autism claims, judge rulesAugust 3, 2023 | finance.yahoo.comKVUE Aug 2023 17.500 callJuly 31, 2023 | benzinga.comLooking At Kenvue's Recent Unusual Options ActivityJuly 26, 2023 | msn.comEdward Jones Initiates Coverage of Kenvue (KVUE) with Buy RecommendationJuly 25, 2023 | msn.comWall Street Goes the Irrational Route with Kenvue Stock (NYSE:KVUE)July 24, 2023 | seekingalpha.comJohnson & Johnson launches Kenvue exchange offerJuly 24, 2023 | msn.comJohnson & Johnson Launches Exchange Offer Regarding Separation of KenvueJuly 24, 2023 | benzinga.comJohnson & Johnson Launches Exchange Offer for Separation of Kenvue Inc.July 24, 2023 | reuters.comJ&J begins share exchange offer for consumer health spin-off KenvueJuly 24, 2023 | markets.businessinsider.comJohnson & Johnson Launches Exchange Offer To Separate KenvueJuly 24, 2023 | finance.yahoo.comKenvue To File Form S-4 Registration Statement in Connection with Johnson & Johnson Exchange Offer AnnouncementJuly 23, 2023 | finance.yahoo.comKenvue Inc. (NYSE:KVUE) Q2 2023 Earnings Call TranscriptJuly 21, 2023 | markets.businessinsider.comWhat 10 Analyst Ratings Have To Say About KenvueJuly 21, 2023 | benzinga.comJ&J Investors Will Soon Be Able To Exchange Shares For Kenvue StocksJuly 20, 2023 | msn.comKenvue stock down despite strong first quarter as solo companyJuly 20, 2023 | msn.comJ&J could reportedly launch Kenvue exchange offer in "coming days"See More Headlines Receive KVUE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Kenvue and its competitors with MarketBeat's FREE daily newsletter. Email Address KVUE Company Calendar Last Earnings7/20/2023Today8/13/2023Ex-Dividend for 9/7 Dividend8/25/2023Dividend Payable9/07/2023Next Earnings (Estimated)10/19/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Toilet preparations Sub-IndustryN/A SectorConsumer Staples Current SymbolNYSE:KVUE CUSIPN/A CIK1944048 Webwww.kenvue.com Phone(732) 524-0400FaxN/AEmployees22,200Year FoundedN/APrice Target and Rating Average Stock Price Forecast$28.11 High Stock Price Forecast$30.00 Low Stock Price Forecast$26.00 Forecasted Upside/Downside+18.5%Consensus RatingHold Rating Score (0-4)2.40 Research Coverage10 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E Ratio18.98 P/E Growth2.72Net IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio0.70 Current Ratio1.17 Quick Ratio0.79 Sales & Book Value Annual Sales$14.95 billion Price / Sales3.04 Cash FlowN/A Price / Cash FlowN/A Book Value$5.77 per share Price / Book4.11Miscellaneous Outstanding Shares1,914,890,000Free FloatN/AMarket Cap$45.42 billion OptionableNot Optionable BetaN/A Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesMr. Thibaut Mongon (Age 52)CEO & Director Comp: $1.91MMr. Paul Ruh (Age 55)Chief Financial Officer Comp: $862.45kMr. Carlton Lawson (Age 54)Group Pres of Europe, Middle East & Africa Comp: $1.16MMs. Kathleen M. Widmer (Age 61)Group Pres of North America & Latin America Comp: $815.39kMs. Ellie Bing Xie (Age 53)Group Pres of Asia Pacific Comp: $1.9MMs. Meredith Stevens (Age 60)Chief Operations Officer Ms. Heather R. Howlett (Age 45)Chief Accounting Officer Mr. Bernardo Tavares (Age 55)Chief Data & Technology Officer Dr. Caroline Tillett (Age 51)Chief Scientific Officer Mr. Matthew Orlando (Age 46)Gen. Counsel More ExecutivesKey CompetitorsEstée Lauder CompaniesNYSE:ELColgate-PalmoliveNYSE:CLAmbevNYSE:ABEVArcher-Daniels-MidlandNYSE:ADMHersheyNYSE:HSYView All CompetitorsInsiders & InstitutionsCapital International Inc. CA Bought 63,600 shares on 8/11/2023Ownership: 0.003%Northern Trust CorpBought 47,100 shares on 8/11/2023Ownership: 0.002%B. Metzler seel. Sohn & Co. AGBought 9,000 shares on 8/11/2023Ownership: 0.000%Baird Financial Group Inc.Bought 7,719 shares on 8/11/2023Ownership: 0.000%PNC Financial Services Group Inc.Bought 2,753 shares on 8/11/2023Ownership: 0.000%View All Insider TransactionsView All Institutional Transactions KVUE Stock - Frequently Asked Questions Should I buy or sell Kenvue stock right now? 10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Kenvue in the last twelve months. There are currently 6 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" KVUE shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in KVUE, but not buy additional shares or sell existing shares. View KVUE analyst ratings or view top-rated stocks. What is Kenvue's stock price forecast for 2023? 10 analysts have issued 12-month price objectives for Kenvue's stock. Their KVUE share price forecasts range from $26.00 to $30.00. On average, they predict the company's stock price to reach $28.11 in the next twelve months. This suggests a possible upside of 18.5% from the stock's current price. View analysts price targets for KVUE or view top-rated stocks among Wall Street analysts. How have KVUE shares performed in 2023? Kenvue's stock was trading at $26.50 at the beginning of 2023. Since then, KVUE shares have decreased by 10.5% and is now trading at $23.72. View the best growth stocks for 2023 here. When is Kenvue's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, October 19th 2023. View our KVUE earnings forecast. How were Kenvue's earnings last quarter? Kenvue Inc. (NYSE:KVUE) posted its quarterly earnings data on Thursday, July, 20th. The company reported $0.32 EPS for the quarter, beating the consensus estimate of $0.30 by $0.02. The firm had revenue of $4.01 billion for the quarter, compared to the consensus estimate of $3.96 billion. The firm's quarterly revenue was up 5.4% compared to the same quarter last year. How often does Kenvue pay dividends? What is the dividend yield for Kenvue? Kenvue announced a quarterly dividend on Thursday, July 20th. Stockholders of record on Monday, August 28th will be paid a dividend of $0.20 per share on Thursday, September 7th. This represents a $0.80 dividend on an annualized basis and a yield of 3.37%. The ex-dividend date is Friday, August 25th. Read our dividend analysis for KVUE. What ETFs hold Kenvue's stock? ETFs with the largest weight of Kenvue (NYSE:KVUE) stock in their portfolio include Putnam Sustainable Leaders ETF (PLDR) and Renaissance IPO ETF (IPO).First Trust US Equity Opportunities ETF (FPX). What guidance has Kenvue issued on next quarter's earnings? Kenvue issued an update on its FY 2023 earnings guidance on Thursday, July, 20th. The company provided earnings per share (EPS) guidance of $1.26-$1.31 for the period, compared to the consensus EPS estimate of $1.23. The company issued revenue guidance of $15.73 billion-$15.88 billion, compared to the consensus revenue estimate of $15.74 billion. When did Kenvue IPO? (KVUE) raised $3.3 billion in an initial public offering (IPO) on Thursday, May 4th 2023. The company issued 151,200,000 shares at a price of $20.00-$23.00 per share. Goldman Sachs, J.P. Morgan, BofA Securities, Citigroup, Deutsche Bank Securities, BNP PARIBAS, HSBC, RBC Capital Markets and UBS Investment Bank acted as the underwriters for the IPO. What is Kenvue's stock symbol? Kenvue trades on the New York Stock Exchange (NYSE) under the ticker symbol "KVUE." When does Kenvue's lock-up period expire? Kenvue's lock-up period expires on Tuesday, October 31st. Kenvue had issued 172,812,560 shares in its public offering on May 4th. The total size of the offering was $3,801,876,320 based on an initial share price of $22.00. After the expiration of Kenvue's lock-up period, company insiders and major shareholders will be able to sell their shares of the company. Who are Kenvue's major shareholders? Kenvue's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Capital International Investors (0.43%), BlackRock Inc. (0.33%), Capital World Investors (0.31%), Boston Partners (0.27%), JPMorgan Chase & Co. (0.24%) and Bank of New York Mellon Corp (0.22%). View institutional ownership trends. How do I buy shares of Kenvue? Shares of KVUE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Kenvue's stock price today? One share of KVUE stock can currently be purchased for approximately $23.72. How much money does Kenvue make? Kenvue (NYSE:KVUE) has a market capitalization of $45.42 billion and generates $14.95 billion in revenue each year. How many employees does Kenvue have? The company employs 22,200 workers across the globe. How can I contact Kenvue? The official website for the company is www.kenvue.com. The company can be reached via phone at (732) 524-0400. This page (NYSE:KVUE) was last updated on 8/14/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kenvue Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.